Characterization of the vasodilator effect of eugenol in isolated human umbilical cord arteries was written by Dantas, Debora de Menezes;Silva, Andressa de Alencar;Pereira-de-Morais, Luis;Bastos, Carla Mikevely de Sena;Calixto, Gabriela Lucena;Kerntopf, Marta Regina;Menezes, Irwin Rose Alencar de;Weinreich, Daniel;Barbosa, Roseli. And the article was included in Chemico-Biological Interactions in 2022.Name: 5-Chloro-N-(4-(N-(cyclohexylcarbamoyl)sulfamoyl)phenethyl)-2-methoxybenzamide This article mentions the following:
Eugenol (EUG) is a phenylpropanoid widely used in the food and cosmetic industries. It is commonly referred to in the literature by its biol. activities such as antioxidant, anti-inflammatory, antimicrobial, and relaxing in organs of laboratory animals, especially in rodent vessels. However, its vasorelaxant potential in human tissue, has not been investigated. Thus, this study characterizes the vasodilatory effect of EUG in the human umbilical artery (HUA). HUAs were isolated, cleaned, sectioned (3-4 mm) and placed in an organ bath (10 mL Krebs Henseleit, 37°C; and carbogenic mixture). EUG (100-1400μM), obtained total relaxation of electromech. contractions induced by KCl (60 mM), and pharmacomech. contractions (30-1200μM), induced by serotonin (10μM) and by histamine (10μM), showing statistically significant concentrations: 600μM, 400μM and 200μM, and EC50 values: 759.8 ± 6.5μM, 229.9 ± 7.9 and 279.0 ± 3.4μM, resp. EUG (1200 and 1400μM) prevented the contraction promoted by BaCl2 (0.1-30 mM), similar to the effects of nifedipine (10μM), sugesting the involvement of EUG in blocking VOCCs. In the presence of tetraethylammonium (10μM), EUG (30-1200μM) did not produce a total relaxation (88.6%), suggesting that an alternative pathway where potassium channels, may partially mediate EUG effect. In the presence of 4-aminopyridine (1 mM), glibenclamide (10μM), and tetraethylammonium (1 mM), EUG relaxed HUAs 100%, although the pharmacol. potency was statistically altered, demonstrating the participation of K+ channels (Kv, KATP, BKCa). Our data indicates that EUG has a vasorelaxant effect on HUAs, had a greater pharmacol. potency in the serotoninergic pathway, showing effective participation of VOCCs and a partial modulation of K+ channels. These data suggest new possibilities for the use of EUG in human vascular dysfunctions, such as preeclampsia. More studies are necessary to confirm the safety and effectivity in future treatments. In the experiment, the researchers used many compounds, for example, 5-Chloro-N-(4-(N-(cyclohexylcarbamoyl)sulfamoyl)phenethyl)-2-methoxybenzamide (cas: 10238-21-8Name: 5-Chloro-N-(4-(N-(cyclohexylcarbamoyl)sulfamoyl)phenethyl)-2-methoxybenzamide).
5-Chloro-N-(4-(N-(cyclohexylcarbamoyl)sulfamoyl)phenethyl)-2-methoxybenzamide (cas: 10238-21-8) belongs to amides. Compared to amines, amides are very weak bases and do not have clearly defined acid–base properties in water. On the other hand, amides are much stronger bases than esters, aldehydes, and ketones. The presence of the amide group –C(=O)N– is generally easily established, at least in small molecules. It can be distinguished from nitro and cyano groups in IR spectra. Amides exhibit a moderately intense νCO band near 1650 cm−1. By 1H NMR spectroscopy, CONHR signals occur at low fields. In X-ray crystallography, the C(=O)N center together with the three immediately adjacent atoms characteristically define a plane.Name: 5-Chloro-N-(4-(N-(cyclohexylcarbamoyl)sulfamoyl)phenethyl)-2-methoxybenzamide
Referemce:
Amide – Wikipedia,
Amide – an overview | ScienceDirect Topics